Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-004740-51Phase 2Completed
Phase 2, randomised trial of paroxetine in psoriasis, sponsored by Agis Industries. Primary endpoint: Primary antipsoriatic efficacy (USE differences). Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-004740-51.